Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis isolates from Eastern Poland

New Microbiologica

Volumn 32, Issue 2, 2009, Pages 147-152

  Paluch Oleś, Jolanta ^a   Koziol Montewka, Maria ^a   Magrys, Agnieszka ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Mutations; Mycobacterium tuberculosis; Rifampin resistance; RpoB gene

Indexed keywords

BACTERIAL DNA; BACTERIAL PROTEIN; RIFAMPICIN; RPOB PROTEIN, MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSTATIC AGENT;

AMINO ACID SUBSTITUTION; ANALYTICAL EQUIPMENT; ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; GENETIC VARIABILITY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; POLAND; TUBERCULOSIS;

AMINO ACID SUBSTITUTION; ANTIBIOTICS, ANTITUBERCULAR; BACTERIAL PROTEINS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENETIC VARIATION; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; POLAND; REAGENT KITS, DIAGNOSTIC; RIFAMPIN; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 67650004052     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. BÁRTFAI Z., SOMOSKÖVI Á., KÖDMÖN C, SZABÓ N., PUSKÁS E., KOSZTOLÁNYI L., FARAGÓ E., MESTER J., PARSONS L.M., SALFINGERM. (2001). Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J. Clin. Microbiol. 39, 3736-3739.
2. HSING-YU H., CHUNG-YU C, LIN-LI C, SHUI-FENG C, YA- HUI C, YI-JING C. (2003). Characterization of ri- fampicin-resistant Mycobacterium tuberculosis in Taiwan. J. Med. Microbiol. 52, 239-245.
3. I-CHING S., DROBNIEWSKI F., MORE P., KEMP M., BROWN T. (2006). Mycobacterium tuberculosis and rifampin resistance. United Kingdom. Emerg. Infect. Dis. 12 (5), 752-759.
4. KAZUE H., CHIYOJI A., MITSUYOSHI T. (1999). Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J. Clin. Microbiol. 37, 2663-2666.
5. MORGAN M., KALANTRI S., FLORES L., PAI M. (2005). A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infectious Diseases, 5, 62-71.
6. PERANDIN E, PINSI G., SIGNORINI C, MANCA N. (2005). Evaluation of INNO-LiPA assay for direct detection of mycobacteria in pulmonary and extrapulmonary specimens. New Microbiol. 29, 133-138.
7. PRASAD R. (2005). MDR-TB: current status. Indian J. Tub. 52, 121-131.
8. SAJDUDA A., BRZOSTEK A., POPLAWSKA M., AUGUSTYNOWICZ- KOPE E., ZWOLSKA Z., NIEMANN S., DZIADEK J., HILLEMANN D. (2004). Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J. Clin. Microbiol. 42, 2425-2431.
9. SHARMA M., SETHI S., MISHRA B., SENGUPTA C, SHARMA S.K. (2003). Rapid detection of mutations in rpoB gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay. Indian J. Med. Res. 117,76-80.
10. SHIN S.S., NARODITSKAYA V., SLOUTSKY A., WERNER B., TIMPERI R., BAYONA J., FARMER RE., BECERRA M.C. (2005). rpoB gene mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis in Northern Lima, Perù. Microb. Drug. Resist. 11, 26- 30.
11. TRAORE H., FISSETTE K., BASTIAN I., DEVLEESCHOUWER M., PORTAELS F. (2000). Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int. J. Tuberc. Lung. Dis. 4 (5), 481-484.
12. VIVEIROS M., LEANDRO C, RODRIGUES L., ALMEIDA J., BETTENCOURT R., COUTO I., CARRILHO L., DIOGO J., FONSECA A., LITO L., LOPES J., PACHECO T., PESSANHA M., QUIRIM J., SANCHO L., SALFINGER M., AMARAL L. (2005) Direct application of the INNO-LiPA Rif.TB Line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis. J. Clin. Microbiol. 43 (9), 4880-4884.